Body Vision Medical在新加坡获得LungVision®的上市前批准，推动用于早期肺癌诊断的AI成像技术-动脉网

Body Vision Medical Receives Pre-Market Approval for LungVision® in Singapore, Advancing AI-Powered Imaging for Early Lung Cancer Diagnosis

CISION 等信源发布 2025-08-05 20:05



可切换为仅中文







WALTHAM, Mass.

马萨诸塞州沃尔瑟姆市

，

Aug. 5, 2025

2025年8月5日

/PRNewswire/ -- Body Vision Medical, a leader in AI-powered intraoperative imaging, is pleased to announce that its LungVision advanced imaging platform has received Pre-Market Approval from

/PRNewswire/ -- Body Vision Medical，一家在人工智能驱动的术中成像领域的领导者，欣然宣布其LungVision高级成像平台已获得上市前批准。

Singapore's

新加坡的

Health Sciences Authority (HSA). This clearance enables full commercialization of LungVision in

卫生科学局 (HSA)。此项批准使 LungVision 能够全面商业化。

Singapore

新加坡

and represents a significant milestone in the company's ongoing mission to improve early and accurate diagnosis of lung cancer worldwide.

代表着公司在全球范围内改善肺癌早期和准确诊断的持续使命中迈出了重要的里程碑。

Lung cancer is a significant health concern in

肺癌是一个重要的健康问题在

Singapore

新加坡

, ranking as the second most common cancer in men and the third most common in women. Over a five-year period (2018-2022), approximately 9,000 cases were diagnosed. According to the Singapore Cancer Registry, most patients are diagnosed at a late stage, reducing the effectiveness of treatment and survival rates.

，位列男性第二大常见癌症，女性第三大常见癌症。在五年期间（2018-2022年），大约诊断出9,000例。根据新加坡癌症登记处的数据，大多数患者在晚期才被诊断出来，这降低了治疗的有效性和存活率。

Improving early diagnosis with advanced imaging technology can have a meaningful impact on patient outcomes..

利用先进的成像技术改善早期诊断可以对患者预后产生有意义的影响。

'Receiving HSA's Pre-Market Approval is an important milestone for physicians and patients in

“获得HSA的上市前批准对医生和患者来说是一个重要的里程碑，

Singapore

新加坡

,' said

，' 说

Benny Krauz

本尼·克劳兹

, Vice President of Regulatory and Quality at Body Vision Medical. 'Physicians will now be able to improve the success of their diagnostic bronchoscopy procedures with real-time three-dimensional imaging, which can lead to a meaningful stage shift in lung cancer diagnostics.'

Body Vision Medical监管与质量副总裁。“医生现在能够通过实时三维成像技术提高其诊断性支气管镜手术的成功率，这可能会在肺癌诊断中带来有意义的阶段转变。”

LungVision transforms any standard two-dimensional fluoroscopic imaging system into an AI-powered 3D imaging system, giving physicians real-time navigation and enhanced visualization to perform more precise bronchoscopic biopsies. The technology supports earlier and more accurate diagnoses of pulmonary nodules—helping improve patient outcomes while keeping procedural costs low..

LungVision 将任何标准的二维荧光透视成像系统转化为人工智能驱动的三维成像系统，为医生提供实时导航和增强的可视化功能，以执行更精确的支气管镜活检。该技术支持对肺结节进行更早和更准确的诊断——有助于改善患者预后，同时保持较低的操作成本。

'Bringing LungVision to

将LungVision带到

Singapore

新加坡

represents an important step forward in enhancing diagnostic accuracy for pulmonary care,' said Daniel Soh, Managing Director for Scanmed Technology. 'This platform aligns with our mission to offer high-quality, innovative solutions that improve patient care. LungVision's ability to enhance early detection and biopsy accuracy is an important advancement for pulmonary care in the region.'.

“代表了在提高肺部护理诊断准确性方面向前迈出了重要一步，” Scanmed Technology董事总经理Daniel Soh表示。“该平台与我们提供高质量、创新解决方案以改善患者护理的使命相契合。LungVision增强早期检测和活检准确性的能力是该地区肺部护理的重要进步。”

For more information about LungVision and its availability in

有关 LungVision 及其可用性的更多信息，请访问

Singapore

新加坡

, please visit

，请访问

https://scanmed.com.sg

or contact Daniel Soh at

或联系Daniel Soh at

dsoh@scanmed.com.sg

About Body Vision Medical

关于Body Vision Medical

Body Vision Medical believes in saving lives through the globalization of innovative medical technology. LungVision provides AI-powered real-time image guidance to address the clinical need for early, definitive lung cancer diagnosis and to enable effective treatment of lung lesions via minimally invasive procedures..

Body Vision Medical相信通过创新医疗技术的全球化来拯救生命。LungVision提供人工智能驱动的实时图像引导，以满足对早期、明确的肺癌诊断的临床需求，并通过微创手术实现对肺部病灶的有效治疗。

Visit

访问

bodyvisionmedical.com

to learn more and connect with us on

了解更多并联系我们

领英

。

About Scanmed Technology

关于Scanmed技术

Scanmed Technology PTE LTD is a leading medical solutions provider in

Scanmed Technology PTE LTD 是一家领先的医疗解决方案提供商，在

Singapore

新加坡

, focused on bringing innovative healthcare technologies to the

，专注于将创新的医疗技术带给

Singapore

新加坡

market. With deep industry experience and a commitment to clinical excellence, Scanmed partners with global innovators to deliver impactful solutions to healthcare professionals.

市场。凭借深厚的行业经验和对临床卓越的承诺，Scanmed与全球创新者合作，为医疗保健专业人员提供有影响力的解决方案。

Contact:

联系：

Mike Hostetler

迈克·霍斯泰特勒

+1.651.366.9584

info@bodyvisionmedical.com

SOURCE Body Vision Medical

来源：Body Vision Medical

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻

FEATURED ON PRNEWSWIRE.COM?